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Abstract
Three macroalgae collected at Madeira Island were included in this study to determine their potential for drug, nutraceutical,
food, or supplement application. Fatty acid content was higher in Zonaria tournefortii (12.32mg g−1 dw) with 16.58% of PUFAs,
eicosapentaenoic acid (C20:5ω3), and arachidonic acid (20:4ω6) having concentrations of 2.59 and 1.17%, respectively. The
anti-thrombogenic and anti-atherogenicity potential was higher for Z. tournefortii due to relevant fatty acids in the biochemical
composition this macroalgae. Lipid classes were assessed in the lipid extract and neutral lipids (NL) were in higher yield in
Asparagopsis taxiformis (51.16%) and lower in Z. tournefortii (26.96%). The glycolipids (GL) were between 36.03 and 16.11%
in Z. tournefortii and Ulva lactuca. Phospholipids (PL) fraction varied from 35.91 and 31.60% in A. taxiformis and
Z. tournefortii. TLC screening identified that U. lactuca contains phytol and cholesterol in its NL, digalactosyldiacylglycerol
in its GL, and cardiolipin and L-α-phosphatidylcholine in its PL. Zonaria tournefortii contains phytol and cholesterol in its NL
classes, and the PL classes contain L-α-phosphatidylethanolamine and 1-(3-sn-phosphatidyl)-rac-glycerol. The macroalgae
A. taxiformis revealed cholesterol in its NL fraction and the same phospholipids as Z. tournefortii in its PL fraction. ATR-
FTIR analysis enabled a “fingerprint” spectra and important sulfation absorption bands were identified, revealing the functional
polysaccharides within these macroalgae. Anti-cholinesterasic activity was assessed in A. taxiformis, with a low IC50 for AChE
(8.92 ± 0.43 μg mL−1) and BuChE (13.96 ± 0.32 μg mL−1), demonstrating dual inhibitory activity, justifying the interest to
identify the active principle which may be the scaffold of a novel drug.
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Introduction
Nowadays, intensive research is conducted worldwide to ex-
plore and determine the nutritive, nutraceutical, pharmaceuti-
cal, and cosmeceutical potential of innumerous extracts from
organic materials. Seaweeds have been included in this effort
due to their intrinsic biochemical composition, derived from
evolutionary adaptation to the harsh conditions of high salt
concentration, desiccation and herbivory, and extreme varia-
tions in sunlight and temperature fluctuation. The sea currents
and wave energy also cause motional pressure to these organ-
isms, since they must remain attached to the substrate, sub-
jected to additional environmental stress, adjusting the meta-
bolic network and developing new metabolites to permit ad-
aptation to this variable habitat (Mišurcová et al. 2011).
Seaweeds have a low lipid content but are considered a
potential source of functional lipids due to their enormous stock
in coastal waters. Among total lipids (TL), lipid composition
and quantity varies according to species, geographical origin,
and environmental conditions (Miyashita et al. 2013). TL are
further divided in lipid classes such as glycolipids (GL), triac-
ylglycerols (TAG), and phospholipids (PL). In these classes,
fatty acids exist as saturated fatty acids (SFAs), monounsaturat-
ed fatty acids (MUFAs), and polyunsaturated fatty acids
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(PUFAs). These last (PUFAs) are essential to human nutrition,
since algae produce PUFAs by de novo synthesis and which
cannot be biosynthesized by almost all heterotrophic organ-
isms, having to be ingested in the diet. Nowadays, seaweeds
are also considered as functional food and nutraceuticals with
health benefits, since they are able to reduce the risk of cardio-
vascular diseases (CVD), diabetes, osteoporosis, and cancer
(Mišurcová et al. 2011). GL is the most common lipid group
and includes monogalactosyl-diacylglycerols (MGDG),
digalactosyl-diacylglycerol (DGDG), and sulfoquinovosyl-
diacylglycerol (SQDG) (Holdt and Kraan 2011). GLs are im-
portant in photosynthetic membranes of higher plants, in algae
and bacteria. In brown seaweeds, GLs are the primary mem-
brane lipids, with high concentration of specific long chain fatty
acids, which include stearidonic acid (18:4n-3) (SDA),
eicosapentaenoic acid (20:5n-3) (EPA), and arachidonic acid
(20:4n-6) (ARA) (Miyashita et al. 2013). SDA is formed by
the desaturation of α-linolenic acid (ALA), and when con-
sumed increases the level of eicosapentaenoic acid (EPA) in
erythrocyte membranes (Lemke et al. 2013). Epidemiological
experiments demonstrated that ingesting long chain ω3 fatty
acids decreases cardiovascular diseases, mainly heart attacks
(Albert et al. 1998). The ω6 fatty acids are particularly impor-
tant in biological systems. ARA participates in the immune
response, prevents thrombosis, helps brain function, and togeth-
er with docosahexaenoic acid (DHA), is correlated with a re-
duction in age-related disorders of the brain and cognitive func-
tions (Hoffman et al. 2009; Kiso 2011). These are the main
components of cell membranes and participate in neuron struc-
ture in the central nervous system (Miyashita et al. 2013).
Macroalgae are also an interesting source of novel mole-
cules which may be the scaffolds of more efficient drugs,
namely against age-related diseases (Barbosa et al. 2014).
Alzheimer’s disease (AD) is a progressive neurodegenerative
disorder, affecting roughly 2% of the population in industrial-
ized countries, which is characterized by synapse degenera-
tion and neuronal death in regions of the brain responsible for
learning and memory processes (Mattson 2004). Two main
strategies exist to improve the cholinergic function in AD,
which are stimulating cholinergic receptors or increasing the
availability of acetylcholine into the neuronal synaptic cleft,
inhibiting the enzyme acetylcholinesterase (AChE, E.C.
3.1.1.7) (Howes et al. 2003). Several pharmaceuticals are
available for this second strategy and include tacrine,
rivastigmine, galantamine, and donepezil; however, the use
of these drugs only slows the progress of the illness and causes
negative side effects, highlighting the need for new sources of
anti-acetylcholinesterasic compounds (Arruda et al. 2012).
The inhibition of butyrylcholinesterase or pseudocholinester-
ase (BuChE, EC 3.1.1.8) may also contribute to the treatment
of AD. BuChE is produced mainly in the liver and catalyzes
butyrylcholine more rapidly, although it is also able to hydro-
lyze acetylcholine (Colovic et al. 2013).
Seaweed extracts and pure compounds have been
researched for their cytotoxic effect in human A549 lung can-
cer cellular lines, due to their unique chemical structures that
could be used as novel drugs (Alwarsamy et al. 2016). Lung
cancer is the most prominent cause of cancer deaths, account-
ing more than one million deaths worldwide per annum (Lee
et al. 2011). This cancer development is characterized by pro-
liferation of anaplastic cells without restraint, invading and
metastasizing to the surrounding tissues and organs
(Marudhupandi et al. 2015). Several factors are responsible
for this illness and include unhealthy diet, inherited genetic
mutations, drug use, hormones, environmental toxins, infec-
tious organisms, and immune conditions, the treatment being
the obliteration of the tumor cells (Gutiérrez-Rodríguez et al.
2018). Standardized treatment of this malignancy is the appli-
cation of synthetic compounds in chemotherapy, which at-
tacks the cancer cells but at the same time is cytotoxic to
normal cells (Alwarsamy et al. 2016). It is therefore of the
utmost importance to discover new sources of bioactive com-
pounds that can reduce this malignancy without the side
effects.
This work intended to determine the potential of these 3
seaweeds, due to their significant abundance in Madeira
Island. This is an effort to search new sources of bioactive
compounds that would help develop purification strategies
to research for new pharmaceutical compounds, namely
displaying anti-cholinesterasic and/or cytotoxic activity
against A549 tumor cell lines. This study will also determine
if these macroalgae are good sources of essential fatty acids.
These assessments could permit to develop new drugs, new




The chlorophyte macroalga Ulva lactuca Linnaeus was col-
lected on 15 of May 2017, in “Santa Cruz” at coordinates 32°
41′ 27″ N and 16° 46′ 25″ W. The rhodophyte Asparagopsis
taxiformis (Delile) Trevisan was collected on 8 of September
2017 and the phaeophyte Zonaria tournefortii (J.V.
Lamouroux) Montagne collected on 7 of July 2017 in “Reis
Magos” beach, coordinates 32° 38′ 48″ N and 16° 49′ 26″ W
in a 10 m maximum depth dive of the Madeiran archipelago.
Samples were transported in seawater and gently rinsed with
filtered fresh water. Afterwards, a primary drying was applied
in which seaweed was frozen at − 35 °C and freeze-dried for
5 days under reduced pressure (4 × 10−4 mbar), with a cooling
trap set at − 56 °C. Samples were milled to 200 mesh particle
size, vacuum packed, and stored at − 35 °C until use.
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Fatty acid determination
The fatty acid (FA) composition was determined according to
Lepage and Roy (1986) with the modifications suggested by
Cohen et al. (1988) and assessed as FAmethyl esters (FAME).
Initially, for the conversion of FAs to FAMEs, a mixture of
ethyl acetate-methanol (1:19 v/v) was added to the dried sam-
ples. These were incubated at 80 °C for 1 h and followed by an
extraction using heptane. The analytical apparatus consisted
of a gas chromatograph (Agilent HP 6890), fitted with a mass
selective detector (Agilent 5973) and a capillary column DB-
225J&W (30 m × 0.25 mm inner diameter, 0.15-μm film
thickness), also from Agilent. Chromatographic settings were:
helium was used as the carrier gas set to a flow rate of
2.6 mL min−1, initial temperature of the oven was set to
35 °C for a period of 0.5 min, subsequently incremented by
25 °C min−1 to 195 °C, followed by 3 °C min−1 to 205 °C and
8 °Cmin−1 to achieve a maximum temperature of 230 °C for a
period of 3min. Injector temperature was set to 250 °C and the
transfer line set to 280 °C with the split ratio at 1:100. FAMEs
were identified, comparing the retention times and mass spec-
tra fragmentation to standards (bacterial acid methyl esters CP
mix and Supelco 37 component FAME mix). The internal
standard was heneicosanoic acid (C21:0). Two measures of
each sample were performed, presented as mean values ±
standard deviation (SD) of FAME and results expressed in
mg g−1 of dry weight (DW).
The index of thrombogenicity (IT) and the index of
atherogenicity (IA), in which lower results indicate a lower
risk to develop those pathologies, was calculated as proposed
by Ulbricht and Southgate (1991) using the following
equations:
IT ¼ 14 : 0þ 16 : 0þ 18 : 0ð Þ=
0:5 ΣMUFAþ 0:5 PUFAω6þ 3 PUFAω3ð Þ þ PUFAω3=PUFAω6ð Þ½ Þ
i
IA ¼ 12 : 0þ 4 14 : 0ð Þ þ 16 : 0ð Þ½ =
ΣMUFAþ PUFAω6þ PUFAω3½ 
Extraction and fractionation
Lipid extraction
The methodology of Folch et al. (1957), with some modifica-
tions, was used to perform the lipid extractions (LE) from the
macroalgae. Initially, 2 g of freeze-dried milled macroalgae
were mixed with 40 mL of CHCl3:MeOH (2:1) .
Subsequently, it was sonicated for 10 min at 37 kHz at
100% and centrifuged at 7197xg at room temperature. The
liquid extract was filtered with a 8-μm pore filter paper, added
to 8 mL of 0.9% NaCl solution, vortexed, and centrifuged at
470xg for phase separation. The upper phase was removed
and discarded, leaving the lipophilic phase. The majority of
the solvent was evaporated in a rotary evaporator and the
residual solvent evaporated in an oven at 35 °C overnight
and weighed. These extracts will from now on be abbreviated
as LE.
Ethanol extraction
The ethanol extracts (EE) were performed with 96% ethanol,
using a Timatic semiautomatic extractor (Technolab, Spello,
Italy), set at a constant pressure and static phase. The program
was set as follows: solvent capacity 1 L, solvent to biomass
ratio 50:1, compression time 3 min, decompression time
6 min, minimum pressure 6 bar, compression pressure
8.5 bar at room temperature (± 23 °C). The number of cycles
was set to 12 cycles, which corresponded to 108 min for each
extraction. Each sample of 20 g was placed in a 100-μmmesh
bag and placed inside a 0.5-L extracting vessel. In the end of
each extraction, the liquid extracts were filtered through a
8-μm Whatman filter and were partly evaporated in a rotary
evaporator and dehydrated completely in an oven, at 35 °C
until complete dryness. After, these were stored under vacuum
at − 35 °C until use.
Lipid classes
LE were fractioned into neutral (N), glycolipid (GL), and
phospholipid (PL) classes. Initially, 50 mg of extract were
solubilized in 2 mL of chloroform and applied to a glass col-
umn with 10 g of 200 to 400 mesh silica particles. Silica was
previously packed with chloroform, with quartz sand beneath
and underneath for protection. Fractionation was performed
using 100 mL of a specific solvent for each class. Neutral
lipids and sterols were extracted with chloroform, glycolipids
with acetone, and phospholipids with methanol. For each ex-
traction, the corresponding solvent containing the lipid class
was collected and dried, initially in a rotary evaporator, after-
wards in an oven at 35 °C. The residue was weighted and
stored at − 35 °C until use.
Thin layer chromatography
The separated lipid classes were assessed using thin layer
chromatography (TLC) with Macherey-Nagel Pre-coated
TLC sheets POLYGRAM SIL G/UV254 (0.20 mm silica gel
60). The TLC mobile phase for neutral lipids was
hexane:diethyl ether:acetic acid (85:15:0.1, v/v), and TLC
plate was revealed with vanillin solubilized in sulfuric acid
(1:100, w/v), with posterior heating at 120 °C in an oven until
complete dryness of the TLC plate. The standards were cho-
lesterol acetate, cholesterol, β-carotene, and phytol. The mo-
bile phase for glycolipids was dichloromethane:methanol
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(85:15, v/v) and the TLC plate was revealed with α-
naphthol:sulfuric acid:water:ethanol (2.4:10:10:80, w/v), and
the TLC plate heated at 120 °C for 3 to 5 min, until pink and
purple spots were detected. The standard used was
digalactosyldiacylglycerol (DGDG). Phospholipids were sep-
arated by polarity and charge. The mobile phase was
chloroform:methanol:ammonium hydroxide (65:25:4, v/v),
revealed with sprayed 10% copper and 8% phosphoric acid
solubilized in water, and placed in an oven at 120 °C until
spots appeared. The standards used were L-α-phosphatidyl-
choline, L-α-phosphatidylethanolamine, 1-(3-sn-phosphati-
dyl)-rac-glycerol sodium salt, 1,2-diacyl-sn-glycerol-
phospho-L-ser ine , card io l ip in sodium sal t , and
lysophosphatidylcholine. The retention factor (Eq. 1) was cal-
culated in millimeters for the separated compounds within
each lipid class, as this is calculated by dividing the distance




The assays to assess anti-acetylcholinesterase (AChE) and
anti-butyrylcholinesterase activities (BuChE) were adapted
from Ellman et al. (1961) modified by Arruda et al. (2012).
In each microplate, serial dilutions of the extracts were pre-
pared in 100 mM phosphate buffer pH 8, in order to obtain
concentrations between 0 and 150 μg L−1. Afterwards,
0.25 U mL−1 acetylcholinesterase or butyrylcholinesterase
were added to each microwell and incubated for 5 min. The
reaction was started by the addition of a substrate mixture,
composed by equal parts of 3 mM 5,5′-dithiobis[2-
nitrobenzoic acid] (DTNB) and 75 mM acetylthiocholine io-
dide (ATChI) for AChE or butyrylthiocholine iodide
(BuTChI) for BuChE. The absorbance at 415 nm was read
at 0, 150, 300, and 450 s in a Bio-Rad Model 680 microplate
reader (Bio-Rad Laboratories, USA). Enzyme inhibition was
determined as the percentage activity of reaction media con-
taining samples and the activity of control without inhibitor.
All samples were tested in quadruplicate, the mean ± SD de-
termined, and results expressed as IC50 (μg mL
−1) and also as
% inhibi t ion at the highest concentrat ion tested
(150 μg mL−1), since it allows comparison between extracts
that did not achieve 50% inhibition but nonetheless present
different activities.
In vitro cytotoxicity
The cytotoxicity against A549 human adenocarcinoma tumor
cell line was assessed using the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay. Briefly, 96
wells plates were seeded with 20,000 A549 cells per well in
Dulbecco’s modified Eagle’s medium (DMEM), supplement-
ed with 2% fetal bovine serum (FBS) and 1% penicillin–
streptomycin mixture (10,000 UI mL−1), in the presence of
known concentrations of the extracts or standard previously
dissolved in dimethyl sulfoxide (DMSO). The microplates
were incubated for 48 h at 37 °C, 5% CO2, and 98% humidity.
Afterwards, 10 μL of 5 mg mL−1 MTT were added and the
microplate was again incubated at 37 °C for 3 to 4 h. The
culture medium was removed and DMSO was added to the
wells to dissolve formazan crystals. The absorbance was read
in a Bio-Rad Model 680 microplate reader at 550 nm. All
samples were tested in quadruplicates, the mean ± SD deter-
mined and results were expressed as IC50 (μg mL
−1) and also
as % inhibition at the highest concentration tested
(200 μg mL−1), as referred above.
Spectroscopic analysis
ATR-FTIR spectra of the samples were obtained with a Perkin
Elmer Spectrum Two, coupled with a Diamond ATR accesso-
ry (DurasamplIR II, Smiths Detection, UK). Thirty-two scans
were acquired in transmittance mode in the range of 2000–
650 cm−1, with a wavenumber resolution of 1 cm−1. All sam-
ples were analyzed in triplicate.
Results
Lipid screening
The amounts of total lipids from each algal species and lipid
classes separated from the total extracts are presented in
Table 1. Total lipids were higher in Z. tournefortii (9.66 ±
0.30 g (100 g)−1 dw), followed by A. taxiformis (6.08 ±
0.45 g (100 g)−1 dw) and U. lactuca (1.33 ± 0.03 g (100 g)−1
dw). Neutral lipids and sterols were in a similar proportion in
the U. lactuca and A. taxiformis extracts (50.63 ± 6.10 and
51.16 ± 4.85%, respectively) and in a lower proportion in
Z. tournefortii (26.96 ± 8.22%). The glycolipids fraction was
between 36.03 ± 8.08 and 16.11 ± 1.36% in Z. tournefortii and
U. lactuca, respectively. The phospholipids fraction did not
differ much between species, varying from 35.91 ± 2.36 to
31.60 ± 1.40% in A. taxiformis and Z. tournefortii,
respectively.
TLC (thin layer chromatography) was used as a rapid and
reliable way to ascertain biochemical differences between
these three different macroalgae, screening the presence of
neutral lipids (NL), glycolipids (GL), and phospholipids
(PL) in the lipid content. TLC results are presented in
Table 2 as a presence (+) or absence (−) of similar spots.
Qualitative assessment of NL was carried out by comparison
using cholesterol acetate, cholesterol, β-carothene, and phytol
standards. The NL of U. lactuca and Z. tournefortii presented
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spots with retention factors (Rf) similar to phytol. Unesterified
sterols with an Rf similar to cholesterol was visible in all the
macroalgae used in this work but esterified sterol and β-
carothene were not detected. For GL fraction, a spot with the
same Rf of digalactosyldiacylglycerol (DGDG) standard was
found in U. lactuca but not on the other macroalgae.
Concerning the phospholipid fraction, standards were L-α-
phosphatidylcholine (PC), L-α-phosphatidylethanolamine
(PE), 1-(3-sn-phosphatidyl)-rac-glycerol sodium salt (PG),
1,2-diacyl-sn-glycero-phospho-L-serine (PS), cardiolipin so-
dium salt (CL), and L-α-lysophosphatidylcholine (LPC).
Ulva lactuca presented a similar Rf developed by CL and
PC. Asparagopsis taxiformis and Z. tournefortii demonstrated
similar Rf with PE and PG standards. None of the macroalgae
had similar Rf developed by PS and LPC standards.
Fatty acids
The results concerning fatty acids (FA) with carbon chain
from C13 to C24 are presented in Table 3. Maximum value
of total FA content was determined in Z. tournefortii (12.32 ±
1.28mg g−1), followed byU. lactuca (7.54 ± 0.92mg g−1) and
A. taxiformis (6.01 ± 0.70 mg g−1). Total SFA were higher in
A. taxiformis (5.65 ± 0.66 mg g−1), comprising about 94% of
total FA, and the remaining being monounsaturated FA
(MUFA). The majority of the SFA determined in
A. taxiformis were palmitic (16:0) and myristic acid (14:0),
Table 1 Total lipid content and
class fractionation of Ulva
lactuca, Zonaria tournefortii, and
Asparagopsis taxiformis
Sample Average ± standard deviation
Ulva lactuca
(Chlorophyta)
Total lipids 1.33 ± 0.03 g (100 g)−1
Neutral and sterols 50.63 ± 6.10%
Glycolipids 16.11 ± 1.36%
Phospholipids 35.84 ± 3.40%
Asparagopsis taxiformis (Rhodophyta) Total lipids 6.08 ± 0.45 g (100 g)−1 dw
Neutral and sterols 51.16 ± 4.85%
Glycolipids 23.68 ± 1.92%
Phospholipids 35.91 ± 2.36%
Zonaria tournefortii (Phaeophyta) Total lipids 9.66 ± 0.30 g (100 g)−1 dw
Neutral and sterols 26.96 ± 8.22%
Glycolipids 36.03 ± 8.08%
Phospholipids 31.60 ± 1.40%
Data for total lipids are mean values ± standard deviation (SD) in g (100 g)−1 of dry weight (dw). Lipid class
fractionation (neutral and sterols, glycolipids, and phospholipids) are described as percentage (%) of total lipid
content
Table 2 Thin layer
chromatography (TLC) per-
formed in Ulva lactuca, Zonaria
tournefortii, and Asparagopsis
taxiformis
Standards U. lactuca A. taxiformis Z. tournefortii
Neutral lipids Cholesterol acetate – – –
Cholesterol + + +
β-carothene – – –
Phytol + – +
Glycolipids DGDG + – –
Phospholipids PC + – –
PE – + +
PG – + +
PS – – –
CL + – –
LPC – – –
Lipid classes comprising the lipid extract performed according to Folch et al. (1957) methodology, using the LE
(lipophilic extract) was performed with CHCl3:MeOH (2:1). The table indicates the presence (+) or absence (−) of
similar retention factor (Rf) spots of the working standards for each lipid classes. Digalactosyldiacylglycerol
(DGDG); L-α-phosphatidylcholine (PC); L-α-phosphatidylethanolamine (PE); 1-(3-sn-phosphatidyl)-rac-glyc-
erol sodium salt (PG); 1,2-diacyl-sn-glycero-phospho-L-serine (PS); cardiolipin sodium salt (CL); L-α-
lysophosphatidylcholine (LPC)
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accounting for almost 72 and 19% of total FA in this
macroalgae. For Z. tournefortii, of the 12.32 ± 1.28 mg g−1
of FA, approximately 40% were SFA, 43% MUFA, and
17% PUFA. As above, the majority of SFA were palmitic
and myristic acid, 32 and 6% of total FA, respectively. The
MUFAwere mainly represented by monounsaturated palmitic
(16:1) and stearic acid (18:1), accounting for almost 27 and
17% of total FA, respectively. Concerning the polyunsaturated
ω3 andω6 FA, these were mainly represented by stearidonic
(18:4ω3), eicosapentaenoic (20:5ω3), docosapentaenoic
(22:5ω3), and arachidonic (20:4ω6) acids, representing 5, 3
for the former and 1% for the last two PUFA, respectively. For
U. lactuca, which contained 7.54 ± 0.92 mg g−1 of FA, ap-
proximately 54% were SFA, 30% MUFA, and 16% PUFA.
Again, palmitic acid represented the majority of SFA, ac-
counting for 50% of total SFA inU. lactuca. The MUFAwere
mainly represented by the monounsaturated stearic (25%) and
palmitic acid (5%). PUFA in U. lactuca were characterized
primarily by α-linolenic, stearidonic, linoleic, and
docosapentaenoic acids, representing 6, 5, 4, and 1%, respec-
tively, of total FA in this macroalgae. The ω6/ω3 ratio was
determined and higher values were achieved in U. lactuca
(0.71) and Z. tournefortii (0.13). It was not possible to calcu-
late this ratio for A. taxiformis, due to undetermined values for
PUFA.
ATR-FTIR analysis
The three macroalgae studied in this work were assessed using
ATR-FTIR analysis (Fig. 1), for comparison between them
and to determine the peaks that characterize each of the spe-
cies. Sixteen important bands were detected from 650 to
2000 cm−1, the transmittance transformed to absorbance and
a comparison was carried out. At 790 cm−1 (A) and 846 cm−1
(B), two small peaks were distinguished which could repre-
sent the C–O–S vibration in the equatorial position and axial
position, respectively. A strong IR band (C) at 1020 cm−1 was
detected, indicating a C–O–C bending of polysaccharides
constituents. Another peak was detected at 1050 cm−1 (D),
representative of C–O–C skeletal vibration and at 1080 cm−1
(E) a vibration of C–O–C structure of polysaccharides.
Likewise, a shoulder at 1161 cm−1 (F) was detected, corre-
sponding to vibration of C–O–C of carbohydrates from poly-
saccharides. Furthermore, at 1222 cm−1 (G), a medium-
Table 3 Fatty acid composition
performed by GC-MS in Ulva
lactuca, Zonaria tournefortii, and
Asparagopsis taxiformis
U. lactuca Z. tournefortii A. taxiformis
mg g−1 % of TFA mg g−1 % of TFA mg g−1 % of TFA
14:00 0.07 ± 0.01 0.95 ± 0.02 0.76 ± 0.08 6.14 ± 0.20 1.14 ± 0.12 18.82 ± 0.18
16:00 3.76 ± 0.41 49.84 ± 1.00 3.97 ± 0.47 32.18 ± 0.57 4.32 ± 0.52 71.86 ± 0.25
18:00 0.07 ± 0 0.86 ± 0.02 0.09 ± 0.01 0.70 ± 0.03 0.14 ± 0.02 2.30 ± 0.02
16:01 0.41 ± 0.04 5.40 ± 0.04 3.30 ± 0.39 26.77 ± 0.47 0.04 ± 0.01 0.72 ± 0.02
18:01 1.86 ± 0.16 24.65 ± 0.07 2.03 ± 0.22 16.47 ± 0.29 0.32 ± 0.04 5.29 ± 0.07
18:2ω6 0.32 ± 0.02 4.23 ± 0.07 n.d. n.d. n.d. n.d.
18:3ω3 0.43 ± 0.01 5.73 ± 0.35 n.d. n.d. n.d. n.d.
18:4ω3 0.35 ± 0.02 4.60 ± 0.11 0.65 ± 0.06 5.24 ± 0.14 n.d. n.d.
20:4ω6 (AA) n.d. n.d. 0.14 ± 0.01 1.17 ± 0.11 n.d. n.d.
20:5ω3 (EPA) n.d. n.d. 0.32 ± 0.01 2.59 ± 0.28 n.d. n.d.
22:5ω3 0.08 ± 0.01 1.11 ± 0.20 0.15 ± 0.01 1.23 ± 0.18 n.d. n.d.
ω3 0.86 ± 0.03 11.44 ± 0.66 1.11 ± 0.06 9.05 ± 0.55 n.d. n.d.
ω6 0.32 ± 0.02 4.23 ± 0.07 0.14 ± 0.01 1.17 ± 0.11 n.d. n.d.
SFA 4.09 ± 0.42 54.28 ± 0.70 4.95 ± 0.57 40.13 ± 0.64 5.65 ± 0.66 94.00 ± 0.06
MUFA 2.26 ± 0.20 30.05 ± 0.08 5.33 ± 0.61 43.24 ± 0.43 0.36 ± 0.04 6.00 ± 0.006
PUFA 1.18 ± 0.05 15.67 ± 0.72 2.04 ± 0.14 16.63 ± 0.94 n.d. n.d.
ω3 HUFA 0.08 ± 0.01 1.11 ± 0.20 0.47 ± 0.02 3.81 ± 0.45 n.d. n.d.
Total mg g−1 7.54 ± 0.92 – 12.32 ± 1.28 – 6.01 ± 0.70 –
ω6/ω3 Ratio 0.71 0.13 n.d.
IT 0.59 0.35 30.02
IA 1.18 1.06 24.57
Data presented are mean values ± standard deviation (SD) of FAME in mg g−1 of dry weight (DW) or in
percentage (%) of total fatty acids (TFA). AA arachidonic acid, EPA eicosapentaenoic acid, ω omega, SFA
saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids, HUFA high unsat-
urated fatty acids, n.d. not detected, IT index of thrombogenicity, IA index of atherogenicity
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intensity S=O vibration arouse and a shoulder at 1256 cm−1
(H) which indicates the asymmetric O=S=O stretching vibra-
tion of sulphate esters with possibly some contribution of
COH, CC, and CO vibrations. A medium-intensity peak was
visualized at 1375 cm−1 (I), representative of symmetric de-
formations in CH2 in proteins and N (CH3)3 methyl bending in
lipids. At 1434 cm−1 (J), a C–H bending vibration was detect-
ed and at 1455 cm−1 (K), a scissoring vibration of CH2 or/and
an asymmetric bending vibration of CH3 of fucose. Between
1510 cm−1 (L) and 1558 cm−1 (M), four peaks emerged and
their presence is attributed to bending vibrations of N-H of
protein amide II and stretching vibrations of C-N. Similarly,
medium-intensity peaks were identified at 1622 cm−1 (N) and
1648 cm−1 (O), representing the stretching vibrations of C=O
of protein amide I. At 1739 cm−1 (P), a small intensity peak
was observed which corresponds to C=O vibration of
aldehyde.
Bioactivity
The anti-acetylcholinesterase (anti-AChE) and anti-
butyrylcholinesterase (anti-BuChE) activities for the lipophil-
ic extract (LE) extracts and the ethanolic extracts (EE) are
presented in Table 4. These extractions were compared to
determine the difference in bioactivity when using extracts
performed using chloroform and methanol (LE) or a scalable
extractor (Timatic) that can be used in the industry with a more
environmental friendly solvent, ethanol (EE). The results have
shown that LE extracts were more active AChE inhibitors
when compared with EE, as seen by the lower IC50 values
and/or higher inhibition percentages at 150 μg mL−1. The
highest activity was found in A. taxiformis extracts, with
IC50 = 8.92 ± 0.43 and 46.33 ± 6.02 μg mL
−1 for LE and EE,
respectively. Concerning BuChE inhibition, once again,
A. taxiformis was more active, with 13.96 ± 0.32 and
28.1 μg mL−1 for LE and EE, respectively. All of these ex-
tracts were double cholinesterase inhibitors, except for
U. lactuca EE, and the high activity of A. taxiformis LE must
be highlighted, with low IC50 values and in the case of BuChE
inhibition, almost four-fold more active than Donepezil stan-
dard, which is used in the treatment of Alzheimer’s disease.
The cytotoxicity in A549 adenocarcinomic human alveolar
basal epithelial cells was also assessed, with results presented
in Table 5. The IC50 results ranged between 98.02 ± 0.23 and




The macroalgae analyzed in this work have a low lipid con-




















Fig. 1 ATR-FTIR spectra, plotting wavenumber (cm−1) by absorbance, for the macroalgae lyophilized with bands from A to P indicating important
peaks
J Appl Phycol (2020) 32:759–771 765
2014; Kendel et al. 2015).Ulva lactuca lipid content was 1.33
± 0.03 g (100 g)−1 dw, which is in the middle of the values
range reported by Santos et al. (2015), who obtained 0.3 g
(100 g)−1 dw U. lactuca produced by aquaculture, and by
Khotimchenko et al. (2002), who reported 3.06 g (100 g)−1
dw in U. lactuca collected in Bodega Bay, California.
Therefore, lipid content can be extremely variable in this spe-
cies, possibly according to environmental differences.
Ragonese et al. (2014) also evaluated A. taxiformis collected
in the Sicilian coast and determined a lipid yield of 12.22 g
(100 g)−1 dw, roughly twice that we have determined (6.08 ±
0.45 g (100 g)−1 dw). The same author analyzed Dictyota
dichotoma and the lipid content was found to be less than
Z. tournefortii, belonging to the same family, these
macroalgae contain 6.27 and 9.66 ± 0.30 g (100 g)−1 dw, re-
spectively. Burreson et al. (1976) determined 42 different
components in the essential oil of A. taxiformis, collected in
Hawaii, and the bromoform CHBr3, used in the past as a
sedative, is the major constituent. It was also stated that al-
though being the favorite edible macroalgae in Hawaii archi-
pelago, the existence of haloforms and halogenated com-
pounds in its essential oil could mean that this macroalgae
could be poisonous when consumed. It was not possible to
compare results concerning lipid classes with other published
works, since few reports exist assessing these lipid groups in
these macroalgae. The most similar work is that of Kendel
et al. (2015), who evaluated U. armoricana and determined
that NL was 55.60% (ours 50.63%), GL was 29.10% (ours
16.11%), and PL is 15.30% (ours 35.11%). Comparing these
results, we can determine that these lipid classes yield varies
significantly, even for macroalgae of the same genus.
The TLC analysis performed for each lipid class revealed that
U. lactuca lipid composition could contain phytol and a type of
cholesterol compound in its NL also revealed the same spots Rf
as DGDG in its GL and developed similar Rf to cardiolipin and
L-α-phosphatidylcholine in its PL. Phytol is a remarkable com-
pound due to its use as a precursor of industrial synthesis of
vitamins E and K (Kendel et al. 2015). The Z. tournefortti also
revealed in its NL classes similar Rf presented by phytol and
cholesterol and the PL classes contain similar Rf presented by
L-α-phosphatidylethanolamine and 1-(3-sn-phosphatidyl)-rac-
glycerol. The A. taxiformis revealed similar spots with an Rf
similar to cholesterol in its NL fraction and spots with similar
Rf presented by phospholipids in Z. tournefortii PL fraction.
Ragonese et al. (2014) assessed these classes in 8 macroalgae
(2 green, 2 red, and 4 brown) and determined that U. rigida
revealed also analogous spots with an Rf similar to L-α-phos-
phatidylcholine. The same author determined that some species
of red and brownmacroalgae also present spots with the same Rf
as presented by L-α-phosphatidylethanolamine and 1-(3-sn-
phosphatidyl)-rac-glycerol.
Table 4 In vitro anti-
cholinesterasic potential of
macroalgae extracts









U. lactuca LE 37.06 ± 1.06 > 150 16.52 ± 4.72 > 150
U. lactuca EE 0 > 150 0 > 150
Z. tournefortii LE 42.73 ± 1.70 > 150 19.59 ± 5.55 > 150
Z. tournefortii EE 40.12 ± 4.61 > 150 30.81 ± 3.26 > 150
A. taxiformis LE 100 8.92 ± 0.43 100 13.96 ± 0.32
A. taxiformis EE 100 46.33 ± 6.02 100 28.10 ± 0.93
Donepezil 95.20 ± 0.40 0.01 ± 0.00 100 55.62 ± 3.47
Galantamine 98.40 ± 1.50 0.43 ± 0.09 37.80 ± 0.90 > 150
For the percentage (%) of inhibition using the concentration of 150 μg mL−1 of extract, data is presented as %.
The IC50 results are presented as the concentration of extract needed, in μg mL
−1 , to inhibit 50% of the enzyme.
LE (lipophilic extract) indicates that extract was performed with CHCl3:MeOH (2:1). EE (ethanolic extract)
indicates that the extract was performed with Timatic extractor using 96% ethanol. AChE acetylcholinesterase,
BuChE butyrylcholinesterase
Table 5 Cytotoxicity effect of macroalgae extracts against A549 tumor
cell line
% toxicity (200 μg mL−1) IC50 (μg mL
−1)
U. lactuca LE 0 > 200
U. lactuca EE 90.15 ± 6.96 140.42 ± 4.99
Z. tournefortii LE n.d. n.d.
Z. tournefortii EE 90.41 ± 1.52 137.64 ± 7.89
A. taxiformis LE 100 98.02 ± 0.23
A. taxiformis EE 20.14 ± 5.65 > 200
Colchicine 71.69 ± 0.96 2.78 ± 0.71
Paclitaxel 97.44 ± 0.66 5.96 ± 0.98
The IC50 results are presented as the concentration of extract needed, in
μg mL−1 , to inhibit tumor cell viability by 50%. LE (lipophilic extract)
performed with CHCl3:MeOH (2:1). EE (ethanolic extract) performed
with Timatic extractor using 96% ethanol. n.d. not determined
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Fatty acids
The FAyield in this work was higher in Z. tournefortii (1.23%
dw), followed by U. lactuca (0.75% dw) and A. taxiformis
(0.6% dw). Schmid et al. (2018) evaluated 61 species of
macroalgae collected along the Southern Australian shore
and also determined the TFA for the Dictyopteris muelleri,
from the same family that Z. tournefortii (Dictyotaceae). The
TFA varied from 1.6 to 4.8%, for Z. turneriana and
D. muelleri, respectively. This author also determined for
Ulva a variation between 0.5 to 1.9% of TFA and for the
Ptilonia australasica and Delisea pulchra, belonging to the
same family as A. taxiformis (Bonnemaisoniaceae), 0.9% and
2.2%, respectively. Our values agree with or were close to the
reported values, with some discrepancy due to environmental
factors such as availability of nutrients in seawater, light avail-
ability, herbivory pressure, seasonal period of harvest, and
geographical location.
Highest amount of SFA was detected in the red alga
A. taxiformis, 94% of total FA of which 72% is comprised
by palmitic acid (C16:0). This result does not agree with of
Mellouk et al. (2017), who reported 23.7% of SFA and 67.8%
of unsaturated fatty acids (UFA) for the same species, from the
Mediterranean, near the Algerian coast. This enormous differ-
ence is not easy to explain, although it is probably due to
environmental differences between the Mediterranean and
the open Atlantic Ocean, such as water temperature and
hydrodynamism. It also raises the need to assess nutritional
profiles of macroalgae collected in different locations and
possibly also at different phases of the life cycle. Gressler
et al. (2010) determined that SFA varied from 51 to 78% and
palmitic acid is the most representative SFA in four species of
red macroalgae, collected in the intertidal zone of Anchieta,
Espírito Santo State, Brazil. SFA composit ion of
Z. tournefortii (40%) and D. muelleri (39%) was similar
(Schmid et al. 2018). The FA composition of the chlorophyte
U. lactuca subjected to different environments was analyzed.
For instance, Cardoso et al. (2017) evaluated this macroalgae
cultivated in fish ponds and demonstrated that SFAwere lower
(38%) when comparing with our results (54%) with palmitic
acid (16:0) accounting for 19% and 50% of total FA, respec-
tively. Mai et al. (1994) assessed the nutritional quality of
U. lactuca for the nutrition of two species of abalone pointing
out that palmitic acid (24%) is a major component of FA
fraction in U. lactuca. The assessment of U. lactuca collected
by Verma et al. (2017) from the intertidal zone, in Port Okha
(Gujarat), India, also revealed high yield of this SFA (31%).
Kendel et al. (2015) evaluated two macroalgae, Ulva
armoricana and Solieria chordalis, from Brittany (France)
and determined that palmitic acid was predominant in these
macroalgae. Furthermore, Sánchez-Machado et al. (2004)
evaluated 5 edible macroalgae, Himanthalia elongata,
Laminaria ochroleuca, Undaria pinnatifida, Palmaria sp.,
and Porphyra sp., along the northwest Iberian Coast, whereas
the SFAvaries from 20.39 to 64.95%, and palmitic acid being
again the major FA, with values between 16.51 until 63.19%
of total FA.
The highest value of MUFA was detected in the
Z. tournefortii (43.27%), followed by U. lactuca (30.04%)
and A. taxiformis (6.01%). The most prominent FA among
MUFA changed between species, since in U. lactuca and
A. taxiformis was the stearic acid, with 24.65 and 5.29%,
respectively, whilst in Z. tournefortii, the major concentration
of MUFAwas palmitic acid, corresponding to 26.80% of total
FA. Cardoso et al. (2017) determined to be the most represen-
tative MUFA (16.6%) in U. lactuca, collected from fish
ponds, the stearic acid with 7.7% of total FA. Dawczynski
et al. (2007) determined that MUFA content varies between
7.8 and 20.7% in 4 dried edible macroalgae Porphyra sp.,
U. pinnatifida, Laminaria sp., and Halymenia fusiforme, with
stearic acid being the most representative, varying from 5.95
to 15.3% of total FA.
The highest content of PUFA was determined in
Z. tournefortii, 2.04 ± 0.14mg g−1 dw (16.58% of TFA), follow-
ed byU. lactuca with 1.18 ± 0.05 mg g−1 dw (15.62% of TFA),
whilst no PUFA was detected in A. taxiformis. Sánchez-
Machado et al. (2004) determined that PUFA content varies
between 16.10 and 69.11% in edible macroalgae, with our
values close to the lowest assessed content. The most represen-
tative PUFA was determined to be species dependent. In
U. lactuca, the α-linolenic acid, 0.43 ± 0.01 mg g−1 dw
(5.71% of TFA), and Z. tournefortii the stearidonic acid, 0.65
± 0.06 mg g−1 dw (5.24% of TFA), are the main PUFA compo-
nents. According to several scientific reports, the most represen-
tative PUFA in seaweed appears to be variable. Cardoso et al.
(2017) andWahbeh (1997) refer that linoleic acid is the principal
PUFA in U. lactuca, composing 9.5 and 9.7%, respectively. On
the other hand,Mai et al. (1994) determined that stearidonic acid
was themost representative PUFA inU. lactuca (14.8%). Verma
et al. (2017), studying this macroalgae, determined that α-
linolenic acid was the major PUFA, coinciding with our finding,
but with higher 14.31% in the TFA. The eicosanoid precursor,
arachidonic acid, 0.14 ± 0.01 mg g−1 dw (1.16% of TFA), and
eicosapentaenoic acid, having 0.32 ± 0.01 mg g−1 dw (2.57% of
TFA), were only determined in Z. tournefortii. Sánchez-
Machado et al. (2004) also demonstrated that the most represen-
tative PUFA is also macroalgae dependent, with arachidonic
acid having the highest content in Porphyra sp. (6.80%),
H. elongata (10.69%), and L. ochroleuca (14.20%).
Stearidonic acid is present in U. pinnatifida with 22.60% and
the eicosapentaenoic acid in E Palmaria sp.with 24.05%. These
different observations allow us to conclude that the major
macroalgae FA content is seasonal dependent, and will vary
depending on the geographical location and ecosystem
dynamics. This conclusion is supported by dependent Nelson
et al. (2002) and Polat and Ozogul (2013).
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The ω6/ω3 ratio in U. lactuca was 0.71 and in
Z. tournefortii 0.13, with no amount of PUFA detected in
A. taxiformis. Sánchez-Machado et al. (2004) determined that
this ratio varies from 0.13 to 1.21 in 5 edible macroalgae,
Cardoso et al. (2017) determined a 0.86 ratio for U. lactuca
grown in fish aquaculture ponds and Schmid et al. (2018)
establish a 0.8 ratio for Z. turneriana collected in the
Australian southern shore. It is currently accepted that human
beings evolved with a ω6/ω3 ratio diet of approximately 1,
but nowadays the western diets are between 15/1 and 16.7/1
ratios, whereas a maximum of 4/1 ratio is considered suitable
to maintain a healthy status (Simopoulos 2002).. Elevatedω6/
ω3 ratio increase the prostanoid thromboxane (TXA2) and
inhibit prostacyclin (PGI2) production which is linked to the
increasing risk of thrombosis (Ulbricht and Southgate 1991).
Moreover, Simopoulos (2002) described in his work that aω6
rich diet could increase blood viscosity, vasospasm, and vaso-
constriction, when a higher consumption of ω3 helps the re-
laxation of large arteries and vessels, due to an increase of
nitric oxide, an endothelium-derived relaxing factor (EDRF),
thus decreasing the atherogenicity effect. Ulbricht and
Southgate (1991) developed two interesting equations, one
for calculating an index of thrombogenicity (IT) and an index
of atherogenicity (IA), where values indicate healthier results.
For the macroalgae included in this work, the ITwas 0.35 for
Z. tournefortii, 0.59 for U. lactuca, and 30.02 for
A. taxiformis. These results indicate an anti-thrombogenic ef-
fect of Z. tournefortii andU. lactuca, but due to the absence of
PUFA in A. taxiformis, this macroalga appears unsuitable for
this purpose. In addition, the toxicity of halogenated com-
pounds in this alga should be pointed out (e.g., Li et al.
2016). For IA, the values were 1.06 for Z. tournefortii, 1.18
for U. lactuca, and 24.57 for A. taxiformis. These results ev-
idence an anti-atherogenicity effect of Z. tournefortii and
U. lactuca, whilst A. taxiformis is confirmed as unsuitable
for this purpose. Vizetto-Duarte et al. (2015) determined these
indices in six different Cystoseira species and determined IT
values varying between 0.54 and 1.61, and IA between 0.67
and 1.94. Belattmania et al. (2018) also analyzed brown
macroalgae fromMorocco and determined IT to vary between
0.04 to 0.25 and IA from 0.55 to 1.35.
These results strongly enforce the possibility of using
U. lactuca and Z. tournefortii lipids to enhance the nutraceutical
characteristics of food products and to develop macroalgae-
based supplements to improve or maintain health. Considering
the above, including U. lactuca and Z. tournefortii in human
nutrition could be a means to reduce theω6/ω3 ratio.
ATR-FTIR
This technique is extensively used for the recognition and
characterization of numerous types of molecules, using the
fact that it delivers an exclusive signature to each compound.
The transmittance variance detected by the equipment in each
wavenumber is due to the relative mass and geometry of the
atoms in the sample. The conformation of the molecules en-
ables resonance between vibrations that will modulate the
spectra (Derenne et al. 2014). The assessment of our samples
allowed distinguishable ATR-FTIR “fingerprints” to be ob-
tained, and two small peaks, most prominent in U. lactuca,
with 790 cm−1 (A) and 846 cm−1 (B), according to Robic et al.
(2009), indicate the presence of ulvans. These complex poly-
saccharides are integrated in the cell wall and due to their
unusual composition and structure considered a functional
biopolymer (Lahaye and Robic 2007). Three well-
distinguished peaks and one shoulder located between 1000
and 1200 cm−1 (C, D, E, and F) indicate the vibration of sugar
rings, overlapping with stretching vibrations of C–OH side
groups and the C–O–C glycosides bonds. According to
Robic et al. (2009), ulvan extracts present strong absorption
at 1055 cm−1, close to our D peak at 1050 cm−1. This is well
distinguished for U. lactuca, due to C–O stretching in rham-
nose and glucuronic acid. A medium-intensity peak at
1222 cm−1 (G) and 1256 cm−1 (H) was detected in the three
macroalgae, indicating polysaccharides with some degree of
sulfation. Generally, sample sulfation intensity is detected be-
tween 1210 and 1260 cm−1 (Gómez-Ordóñez and Rupérez
2011). In green macroalgae this would be represented by
ulvans, in red macroalgae by carrageenans, and for brown
macroalgae by fucoidan. These polysaccharides are valuable
for their intrinsic rheological qualities (carrageenans) or for
their bioactive properties (ulvans and fucoidan). For example,
fucoidan, a fucose-enriched sulfated polysaccharide with a
high degree of complexity, is described as a compound with
anti-inflammatory, anticoagulant, antithrombotic, and antiox-
idant properties (Senthilkumar et al. 2013) and is exploited as
an additive in some products for health food, drinks, and cos-
metics (Pádua et al. 2015). These biological properties will
vary, depending on the density and specific positions of these
sulfated groups (Berteau and Mulloy 2003).
Bioactivity
Anti-acetylcholinesterasic activity was higher for LE when
compared with EE, which can be seen by the lower IC50 re-
sults and/or the higher % inhibition at the highest concentra-
tion tested. These results suggest that the molecules responsi-
ble for this effect are either lipids or similar compounds. The
macroalgae A. taxiformis stands out, presenting 100% inhibi-
tion using 150 μg mL−1 for both types of extract and the
lowest IC50 results (8.92 ± 0.43 μg mL
−1) using LE extract.
The EE of this macroalgae also delivered good results, with an
IC50 of 46.33 ± 6.02 μg mL
−1. For comparison, two widely
used drugs in Alzheimer’s patients were used in this work:
donepezil, a piperidine derivative, and galantamine, an alka-
loid. Although the activity shown by these compounds was
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much stronger, it must be pointed out that the activities of the
LE and EE A. taxiformis extracts, which are mixtures contain-
ing a high variety of compounds, are nonetheless high enough
to justify a purification to identify the active molecules. These
results are far higher than those presented by Stirk et al.
(2007), who evaluated 7 macroalgae species from the east
coast of South Africa determining the IC50 results for AChE
inhibitory activity. The best result obtained by those authors
(IC50 of 4800 μg mL
−1 for Dictyota humifusa) is more than
500 times less active than the A. taxiformis EE presented here-
in. The most interesting result reported by Stirk et al. (2007) is
the effect of seasonality on the activity, which may be due to
differences in environmental pressures such as predation
along the year cycle. The work of these authors point out the
need to carry out studies determining the best phase of the
algal cycle to collect biomass with significant bioactivity.
Most of the extracts tested also inhibited butyrylcholinester-
ase, and once again A. taxiformis was most prominent, with LE
approximately two-fold more active than EE. In addition, the
dual inhibitory activity of AChE and BuChE is quite positive,
since there is evidence that compounds with this feature can
intensify the effectiveness of AD treatment, possibly by also
reducing the formation of β-amyloid plaques (Giacobini 2003).
Overall, the results obtained further reinforce the potential of
A. taxiformis extracts for further studies to inhibit these en-
zymes, since they are much stronger than results reported by
other authors for macroalgae extracts. Cystoseira species ex-
tracts (Custódio et al. 2016) have a dual AChE and BuChe
inhibition, but at much higher concentrations (between 1000
and 10,000 μg mL−1) than the ones used herein (0.293 and
150 μg mL−1). What is mentioned above for AChE inhibition
is also true for BuChE, i.e., that the compounds with higher
anti-cholinesterasic activity are probably lipids or compounds
with a similar polarity, since LE extracts were consistently bet-
ter inhibitors of both enzymes. To avoid the use of chloroform,
the ethanolic extraction (EE) could be optimized to effectively
extract these compounds, varying the time and number of com-
pression and decompression cycles. These parameters enable
the variable pressure for solvent recirculation through the sam-
ple. Solvent mixtures could also be applied, adding ethyl ace-
tate, an extensively used solvent in the food industry to decrease
polarity. This effort is necessary to develop “greener” method-
ologies to produce extracts comprising of apolar extracts that
could perform equally, efficient reducing the usage of toxic
solvents, known to be harmful to the environment.
The cytotoxicity against A549 tumor cell line does not
present a clear activity pattern as in the case of anti-
cholinesterasic act ivi t ies . The A. taxi formis LE,
Z. tournefortii EE, and U. lactuca EE were the most active
extracts, with IC50 values of 98.02 ± 0.23, 137.64 ± 7.89, and
140.42 ± 4.99 μg mL−1, respectively. Asparagopsis taxiformis
LE again exhibited the best results, highlighting the bioactive
potential of this macroalgae and extract for further compound
purification. These values are comparable with others reports
of activity against this cell line, such as the IC50 of
110 μg mL−1 obtained by Dellai et al. (2013), using
Laurencia obtusa MeOH:CHCl3 extracts. Kang et al. (2017)
obtain an IC50 of 50 μg mL
−1 against A549 cells, inducing
apoptosis, using Gracilariopsis lemaneiformis. However, this
result corresponds to purified polysaccharides and is therefore
not comparable with the extracts presented here, since they
were extracted with distilled water. Additionally, an
Ecklonia cava ethyl acetate extract displayed in vitro metasta-
tic activity against A549 cells, although it did not affect cell
viability (Lee et al. 2011). These results suggest that aqueous
and fractions of intermediate polarity may also have antican-
cer potential and should also be investigated. Concerning the
results presented herein, the extracts and/or isolated com-
pounds isolated thereof will be tested against other cell lines,
namely obtained from non-tumor origin, and the mechanism
of toxicity will be assessed. However, in a preliminary study,
cytotoxicity against a cell line is a good indicator of potential
for further studies using a bioassay guided approach.
Conclusion
The macroalgae analyzed in the present work present interest-
ing characteristics that justify further research. Ulva lactuca
and Z. tournefortii have qualities that point out their interest in
nutrition, such as their low lipid content and favorable IT and
IA values. The presence of polysaccharides such as ulvans or
fucoidans with some degree of sulfation, as indicated by ATR-
FTIR results, also points out the interest of these two
macroalgae as staple food, if not for human consumption, a
least in animal feed. Concerning A. taxiformis, the high per-
centage of SFA and the extremely high IA and IT values and
other studies which point out to the toxicity of its halogenated
compounds do not recommend it as an edible macroalgae, but
it displays biological activities that indicate its pharmaceutical
interest. The low IC50 values for anti-cholinesterasic activity,
particularly those for the LE extract, and the fact that both
A. taxiformis extracts present dual AChE and BuChE inhibi-
tion, are good indicators of the possibility of finding a good
candidate scaffold for an anti-Alzheimer Disease drug.
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